MLL3 mutation in cells results in the defect of BRCA1-associated protein 1 (BAP1) recruitment to enhancers of tumor-suppressor genes, which represses enhancer activity and promotes tumorigenesis (Wang et al., 2018). Here, BAP1 is linked to neoplasm.